Fenretinide: A Novel Treatment for Endometrial Cancer

Resistance to progestin treatment is a major hurdle in the treatment of advanced and reoccurring endometrial cancer. Fenretinide is a synthetic retinoid that has been evaluated in clinical trials as a cancer therapeutic and chemo-preventive agent. Fenretinide has been established to be cytotoxic to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mittal, Navdha, Malpani, Saurabh, Dyson, Matthew, Ono, Masanori, Coon, John S., Kim, Julie J., Schink, Julian C., Bulun, Serdar E., Pavone, Mary Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207704/
https://www.ncbi.nlm.nih.gov/pubmed/25340777
http://dx.doi.org/10.1371/journal.pone.0110410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207704/
https://www.ncbi.nlm.nih.gov/pubmed/25340777
http://dx.doi.org/10.1371/journal.pone.0110410

Ejemplares similares